Centene Co. (NYSE:CNC) Shares Sold by EntryPoint Capital LLC

EntryPoint Capital LLC reduced its stake in shares of Centene Co. (NYSE:CNCFree Report) by 9.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,708 shares of the company’s stock after selling 570 shares during the quarter. EntryPoint Capital LLC’s holdings in Centene were worth $346,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Capital Advisors Ltd. LLC raised its position in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after buying an additional 177 shares in the last quarter. Rialto Wealth Management LLC bought a new stake in Centene during the fourth quarter worth approximately $30,000. OFI Invest Asset Management acquired a new stake in Centene in the fourth quarter worth approximately $33,000. SRS Capital Advisors Inc. increased its position in shares of Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after purchasing an additional 267 shares during the period. Finally, Riverview Trust Co raised its stake in shares of Centene by 172.7% in the 4th quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after buying an additional 480 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analysts Set New Price Targets

CNC has been the topic of a number of research analyst reports. Jefferies Financial Group lowered Centene from a “hold” rating to an “underperform” rating and lowered their target price for the stock from $68.00 to $52.00 in a report on Tuesday, December 10th. Stephens lowered their price objective on shares of Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a research note on Friday, December 13th. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Barclays lifted their price target on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research report on Friday, December 13th. Finally, Wells Fargo & Company cut their price objective on Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, Centene currently has an average rating of “Moderate Buy” and an average price target of $79.92.

Read Our Latest Research Report on CNC

Centene Stock Performance

Shares of Centene stock opened at $60.58 on Thursday. The stock has a market cap of $30.05 billion, a PE ratio of 9.71, a price-to-earnings-growth ratio of 0.80 and a beta of 0.40. Centene Co. has a 12 month low of $55.03 and a 12 month high of $80.59. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. The business has a fifty day simple moving average of $60.04 and a 200-day simple moving average of $62.88.

Centene (NYSE:CNCGet Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.31. The firm had revenue of $40.81 billion during the quarter, compared to analyst estimates of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the company posted $0.45 EPS. On average, sell-side analysts anticipate that Centene Co. will post 6.86 EPS for the current fiscal year.

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.